AU769889B2 - Isolated nucleic acids of the p-Hyde family, P-Hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer - Google Patents

Isolated nucleic acids of the p-Hyde family, P-Hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer Download PDF

Info

Publication number
AU769889B2
AU769889B2 AU66046/00A AU6604600A AU769889B2 AU 769889 B2 AU769889 B2 AU 769889B2 AU 66046/00 A AU66046/00 A AU 66046/00A AU 6604600 A AU6604600 A AU 6604600A AU 769889 B2 AU769889 B2 AU 769889B2
Authority
AU
Australia
Prior art keywords
hyde
nucleic acid
cells
protein
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU66046/00A
Other languages
English (en)
Other versions
AU6604600A (en
Inventor
Rema Menon
Augustinus Rinaldy
Mitchell S. Steiner
Chiang Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tennessee Research Foundation
Original Assignee
University of Tennessee Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/499,817 external-priority patent/US7043009B1/en
Application filed by University of Tennessee Research Foundation filed Critical University of Tennessee Research Foundation
Publication of AU6604600A publication Critical patent/AU6604600A/en
Application granted granted Critical
Publication of AU769889B2 publication Critical patent/AU769889B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
AU66046/00A 1999-04-29 2000-05-01 Isolated nucleic acids of the p-Hyde family, P-Hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer Ceased AU769889B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US13160799P 1999-04-29 1999-04-29
US30245799A 1999-04-29 1999-04-29
US09/302457 1999-04-29
US60/131607 1999-04-29
US09/499,817 US7043009B1 (en) 2000-02-08 2000-02-08 Providing customer data to an automatic call distribution system agent
US09/499817 2000-02-08
PCT/US2000/011456 WO2000071564A2 (fr) 1999-04-29 2000-05-01 Acides nucleiques isoles de la famille p-hyde, proteines p-hyde et procede pour induire la susceptibilite a l'induction de la mort cellulaire programmee pendant le cancer

Publications (2)

Publication Number Publication Date
AU6604600A AU6604600A (en) 2000-12-12
AU769889B2 true AU769889B2 (en) 2004-02-05

Family

ID=27384176

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66046/00A Ceased AU769889B2 (en) 1999-04-29 2000-05-01 Isolated nucleic acids of the p-Hyde family, P-Hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer

Country Status (5)

Country Link
EP (1) EP1328151A4 (fr)
JP (1) JP2003529321A (fr)
AU (1) AU769889B2 (fr)
CA (1) CA2371828A1 (fr)
WO (1) WO2000071564A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835812B1 (en) 1999-04-29 2004-12-28 University Of Tennessee Research Corporation Human p-Hyde proteins
CN113106082B (zh) * 2021-05-27 2022-11-04 云南师范大学 动物粪便宏基因组来源的丙氨酸消旋酶及其制备和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997022695A2 (fr) * 1995-12-20 1997-06-26 Fondation Jean Dausset-Ceph Sequences nucleotidiques, proteines, medicaments et agents diagnostiques utiles dans le traitement du cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A3 (fr) * 1999-07-29 2004-04-21 Research Association for Biotechnology Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
EP1254236A2 (fr) * 2000-02-11 2002-11-06 Incyte Genomics, Inc. Enzymes metabolisant les medicaments
EP1268526A4 (fr) * 2000-03-24 2004-09-08 Fahri Saatcioglu Molecules d'acide nucleique specifiques de la prostate ou des testicules, polypeptides, techniques de diagnostic, et traitement therapeutique

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997022695A2 (fr) * 1995-12-20 1997-06-26 Fondation Jean Dausset-Ceph Sequences nucleotidiques, proteines, medicaments et agents diagnostiques utiles dans le traitement du cancer

Also Published As

Publication number Publication date
CA2371828A1 (fr) 2000-11-30
AU6604600A (en) 2000-12-12
JP2003529321A (ja) 2003-10-07
WO2000071564A2 (fr) 2000-11-30
WO2000071564A8 (fr) 2001-10-04
WO2000071564A3 (fr) 2003-05-01
EP1328151A2 (fr) 2003-07-23
EP1328151A4 (fr) 2004-06-16

Similar Documents

Publication Publication Date Title
EP0785216B1 (fr) Gène BRCA2 lié au chromosome 13, de la susceptibilité au cancer du sein
EP1260520B1 (fr) Gène BRCA2 impliqué dans la susceptibilité au cancer du sein, du chromosome 13
US5709999A (en) Linked breast and ovarian cancer susceptibility gene
AU686004B2 (en) In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene
US5693473A (en) Linked breast and ovarian cancer susceptibility gene
US7655778B2 (en) SISP-1, a novel p53 target gene and use thereof
WO1997030108A1 (fr) Proteines caractrisees de brca1 et brca2 et procedes de criblage et de traitement
WO1997022689A9 (fr) Gene de predisposition au cancer du sein lie au chromosome 13
JP4771576B2 (ja) Ｇａｓｃ１遺伝子
AU769889B2 (en) Isolated nucleic acids of the p-Hyde family, P-Hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
US8148343B2 (en) Tumor suppressor factor
US20080145347A1 (en) p-Hyde sequences in the Rat
US6835812B1 (en) Human p-Hyde proteins
JP3241736B2 (ja) １７ｑ−連鎖乳癌および卵巣癌感受性遺伝子
US6337192B1 (en) MMSC1-an MMAC1 interacting protein
JP4280878B2 (ja) Ｍａｓｌ１遺伝子
JP2000325087A (ja) Ｔｓａ２３０６遺伝子
US6291173B1 (en) MMSC2—an MMAC1 interacting protein
AU773601B2 (en) Chromosome 13-linked breast cancer susceptibility gene
ZA200104562B (en) Chromosome 17p-linked prostate cancer susceptibility gene.

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)